Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More Auto and Transport Industry News Embraer S.A. (NYSE: EMBJ) delivers strongest second quarter in company history Embraer's Q2 revenue hit $2.2 billion with a 38% adjusted net income surge, and shares neared a 52-week high as 2026 EBIT and cash targets were raised. byVenkateshAugust 12, 2026